Thomas Skjærlund Grønnebæk,
Clinical Trial Manager
My name is Thomas Skjærlund Grønnebæk and I am a Clinical Trial Administrator and part of the clinical development team at NMD Pharma. As part of my role, I support the Head of Clinical Operations and Chief Medical Officer with clinical project management activities and contribute to the oversight of the clinical studies sponsored by NMD Pharma. Because we are a small team, my tasks vary quite a lot which is great to learn the complexities of clinical research in the pharmaceutical industry. During my first four months at NMD Pharma, my tasks ranged from writing systematic reviews, filing of central trial documents, reviewing protocols, preparation of scientific presentations to coordinating ethics submissions and database coding with investigators at collaborating universities. My first major tasks have been to set up a trial master file for the company’s first Phase I/IIa clinical study and to help initiate observational studies with the aim to identify new potential target populations for NMD Pharma’s lead drug candidate NMD670.
Prior to joining NMD Pharma, I completed a PhD in Skeletal Muscle Physiology at Aarhus University. During my studies, I was a project leader on three clinical studies focusing on muscle metabolic abnormalities in cardiovascular disease and exercise as a countermeasure. I authored/co-authored nine scientific publications and was a visiting PhD scholar at the Oklahoma Medical Research Foundation.
I feel very privileged to be at a company where I can use my background in muscle physiology and clinical research to aid the development of innovative treatments for patients with neuromuscular disease. I am surrounded by leading experts in physiology, drug discovery and clinical research and it is a great environment for learning.
From what I have experienced during my first four months, NMD Pharma is a company with great ambitions and with an open and welcoming atmosphere where sharing of knowledge and information across the various teams is actively encouraged. One thing I particularly appreciate is our monthly seminars with contributions from the different teams and updates on high level goals and milestones from the management team. /Dec. 2021
Since the interview has been conducted, Thomas has been promoted to Clinical Trial Manager. /April 2022